Search for a research project
Other search option(s)
30 Result(s)
Terminated research projects = 
Funded by an IRDiRC member = 
Member of a ERN = 
Research projects
FRANCE
ILE-DE-FRANCE
CHÂTENAY-MALABRY
Proarrhythmic mechanisms dependent on sodium and calcium
Faculté de Pharmacie - Université Paris-Sud
Laboratoire "Signalisation et Physiopathologie Cardiovasculaire" - INSERM UMR-S 1180
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
TREATKCNQ: Targeted treatment for KCNQ related encephalopathies: retigabine analogues, repurposed drugs and allele specific knock down - FR
Faculté de Médecine de la Timone
Marseille Medical Genetics Center - Inserm U1251
ITALY
CAMPANIA
NAPOLI
TREATKCNQ: Targeted treatment for KCNQ related encephalopathies: retigabine analogues, repurposed drugs and allele specific knock down - IT
Azienda Ospedaliera Universitaria "Federico II"
Dipartimento di Neuroscienze
CANADA
Colombie-Britannique
VICTORIA
Long QT Syndrome in Northern British Columbia:Understanding the impact
University of Victoria
Community Genetics Research Program/Island Medical Program
FRANCE
ILE-DE-FRANCE
PARIS
Phenotypic and genetic studies on long QT syndrome, familial
CHU Paris Nord-Val de Seine - Hôpital Xavier Bichat-Claude Bernard
Service de cardiologie - Rythmologie
FRANCE
PAYS DE LA LOIRE
NANTES
LQTS-NEXT: To the NEXT level of risk prediction in patients with Long QT Syndrome - FR
Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291
GERMANY
Hamburg
HAMBURG
LQTS-NEXT : To the NEXT level of risk prediction in patients with Long QT Syndrome - Deep Learning -DE (partner 2)
Syte Capital GmbH
GERMANY
Nordrhein-Westfalen
MÜNSTER
LQTS-NEXT : To the NEXT level of risk prediction in patients with Long QT Syndrome - Risk prediction -DE (partner 1)
Universitätsklinikum Münster
Institut für Genetik von Herzerkrankungen
ITALY
LOMBARDIA
MILANO
LQTS-NEXT: To the NEXT level of risk prediction in patients with Long QT Syndrome - IT
Auxologico Pier Lombardo
Centro per lo Studio e la Cura delle Aritmie Cardiache di Origine Genetica
ITALY
LOMBARDIA
MILANO
SILENCELQTS: SGK1 inhibition as a novel therapeutic approach in Long QT syndrome - IT
Auxologico Pier Lombardo
Centro per lo Studio e la Cura delle Aritmie Cardiache di Origine Genetica
SWEDEN
Region Västerbotten
UMEÅ
Familial long QT syndrome and familial hypertrophic cardiomyopathy in Sweden: clinical, molecular, genetic and experimental studies
Umeå Universitet
Department of Public Health and Clinical Medicine
SWITZERLAND
Suisse Alémanique
BERN
Co-regulation of cardiac ion channels: focus on the sodium channel Nav1.5
Universität Bern
Institute of Biochemistry and Molecular Medicine (IBMM)
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Modeling a rare autonomic disease
Institution: Information not provided - US
GERMANY
Bayern
MÜNCHEN
Characterization of the arrhythmia substrates in hereditary in comparison to non-hereditary arrhythmogenic cardiomyopathy by cardiac magnetic resonance imaging
Helios Klinikum München West
Klinik für Kardiologie und Internistische Intensivmedizin
CANADA
Colombie-Britannique
VICTORIA
Silent Genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations
University of Victoria
Community Genetics Research Program/Island Medical Program
CANADA
Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
Modelisation and Therapeutic Approaches for Rare Diseases
Université de médecine Aix-Marseille Université
Centre de Génétique de Marseille (Marseille Medical Genetics - MMG)
SPAIN
Andalucía
SEVILLA
Development of bioinformatic tools for the automatic handling of secondary findings and their use in genetic and pharmacogenetic counseling
Fundación Progreso y Salud
Área de bioinformática clínica
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Centro de Regulación Genómica
Archivo europeo de genomas y fenomas del CRG
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Clínic de Barcelona
Servicio de Inmunologia
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Universitari Vall d'Hebron
Laboratorio de Genética
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital de la Santa Creu i Sant Pau
Servicio de Genética
SPAIN
Cataluña
ESPLUGUES DE LLOBREGAT
Federated network for functional genomics of undiagnosed and rare diseases, RareFunction
Fundació Sant Joan de Déu - Institut de Recerca Sant Joan de Déu
Grupo de investigación en Neurogenética y Medicina Molecular
SPAIN
Cataluña
ESPLUGUES DE LLOBREGAT
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Sant Joan de Déu Barcelona
Servicio de Laboratorio
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Universitari de Bellvitge
Unidad de Genética Molecular
SPAIN
Madrid
MADRID
Identification of new genes causing rare diseases in pediatric patients, searching of genetic pharmacological targets, and drugs discovery, the steps for a personalized medicine
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en enfermedades raras, mitocondriales y neuromusculares
Multicentric Research projects
- Ziekenhuis Netwerk Antwerpen (ZNA) - Campus Middelheim
- Neurologie
- Amsterdam UMC, locatie AMC
- Afdeling Cardiologie
- Amsterdam UMC, locatie AMC
- Afdeling Cardiologie
- AP-HP. Centre - Université de Paris - HEGP Hôpital Européen Georges Pompidou
- Thérapie cellulaire en pathologie cardiovasculaire
BELGIUM
ANTWERPEN
ANTWERPEN
TREATKCNQ: Targeted treatment for KCNQ related encephalopathies: retigabine analogues, repurposed drugs and allele specific knock down
NETHERLANDS
Noord-Holland
AMSTERDAM
LQTS-NEXT: To the NEXT level of risk prediction in patients with Long QT Syndrome
NETHERLANDS
Noord-Holland
AMSTERDAM
SILENCELQTS: SGK1 inhibition as a novel therapeutic approach in Long QT syndrome
FRANCE
ILE-DE-FRANCE
PARIS